β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study

Autor: J. Tankovic, S. Gallah, Y. Benzerara, H. Bensekri, Jean-Luc Mainardi, Sophie Vimont, Marc Garnier, Guillaume Arlet, P.-L. Woerther
Přispěvatelé: Centre d'Immunologie et de Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Microbiology (medical)
Bacilli
Klebsiella pneumoniae
education
030106 microbiology
medicine.disease_cause
Sensitivity and Specificity
beta-Lactamases
Specimen Handling
law.invention
Microbiology
03 medical and health sciences
law
Intensive care
Gram-Negative Bacteria
Bronchopneumonia
polycyclic compounds
medicine
Humans
Prospective Studies
ComputingMilieux_MISCELLANEOUS
biology
Pseudomonas aeruginosa
business.industry
Bacterial pneumonia
General Medicine
biochemical phenomena
metabolism
and nutrition

bacterial infections and mycoses
Antimicrobial
medicine.disease
biology.organism_classification
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Body Fluids
3. Good health
Stenotrophomonas maltophilia
Infectious Diseases
Gram staining
Gram-Negative Bacterial Infections
business
Zdroj: Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2018, 24 (4), pp.402-408. ⟨10.1016/j.cmi.2017.07.030⟩
ISSN: 1198-743X
1469-0691
DOI: 10.1016/j.cmi.2017.07.030⟩
Popis: Objectives Incidence of extended-spectrum β-lactamase-producing Gram-negative bacilli (ESBL-PE-GNB)-related infections is worryingly increasing worldwide. ESBL-PE-GNB detection directly on bronchial aspirate samples (BAS) performed for suspected pneumonia may help save empirical carbapenems. Our objectives were to optimize β-LACTA™ test (BLT) realization and evaluate BLT performance for ESBL-PE-GNB detection directly on BAS. Methods We studied BLT technical optimization using BAS of different matrix types spiked with increasing concentrations of CTX-M-15-producing Klebsiella pneumoniae; in vitro validation of BLT diagnostic performance on 17 ESBL enzymes, belonging to CTX-M, SHV, TEM, OXA, GES, VEB and PER groups; and clinical validation of BLT performance on 126 BAS prospectively collected from seven intensive care units. Results After optimization, BLT detected with 100% sensitivity the presence of CTX-M-15-producing K. pneumoniae spiked in sterile BAS for inoculums upon two or more GNB per field upon microscopic Gram staining examination (MGSE). The BLT accurately detected the 17 ESBLs tested at 10 6 CFU/mL and all ESBLs except Pseudomonas aeruginosa –related OXA-14 at 10 4 CFU/mL. Among the 126 BAS of the validation cohort, 21 (17%) gave positive BLT (ten in BAS positive and 11 in BAS negative on MGSE). All BLT-positive BAS grew with ESBL-PE-GNB, including five hyper-L2-producing Stenotrophomonas maltophilia strains. BLT detected ESBL-PE-GNB directly on clinical BAS positive for GNB on MGSE and/or growing with ≥10 4 CFU/mL with 100% sensitivity, specificity, and positive and negative predictive values. Conclusions BLT is an accurate tool for ESBL-PE-GNB detection directly on BAS. Further studies are needed to evaluate the impact of BLT-guided early antimicrobial de-escalation strategies.
Databáze: OpenAIRE